Christopher Daugherty, MD, is a board certified medical oncologist, UChicago Medicine credentialed hematologist, and Professor of Medicine with over 20 years of experience in diagnosing, treating, and caring for patients with a wide spectrum of oncologic and hematologic disorders and malignant conditions.
Dr. Daugherty's research focuses on ethical issues involved in the care of cancer patients. He is a national and international authority on doctor-patient communication, decision-making, end-of-life care, and informed consent as it relates to the care of cancer patients and their participation in clinical research. In addition, he has served as a local medical director for Vitas Hospice in Chicago. (Dr. Daugherty has pursued this as an interest outside his University of Chicago obligations, and has disclosed this to the university.) He also serves as the Chair of the Biological Sciences Division’s Institutional Review Board.
He has received multiple awards and grants for his research from several organizations, including the American Society of Clinical Oncology, the American Society of Oncology, the Soros Foundation, and the National Institutes of Health.
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors.
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors. Haematologica. 2023 08 01; 108(8):2234-2239.
PMID: 36655425
Utilization of an Electronic Patient-Reported Outcome Platform to Evaluate the Psychosocial and Quality-of-Life Experience Among a Community Sample of Ovarian Cancer Survivors.
Utilization of an Electronic Patient-Reported Outcome Platform to Evaluate the Psychosocial and Quality-of-Life Experience Among a Community Sample of Ovarian Cancer Survivors. JCO Clin Cancer Inform. 2022 08; 6:e2200035.
PMID: 35985004
Impact of the COVID-19 Pandemic on Oncologist Burnout, Emotional Well-Being, and Moral Distress: Considerations for the Cancer Organization's Response for Readiness, Mitigation, and Resilience.
Impact of the COVID-19 Pandemic on Oncologist Burnout, Emotional Well-Being, and Moral Distress: Considerations for the Cancer Organization's Response for Readiness, Mitigation, and Resilience. JCO Oncol Pract. 2021 07; 17(7):365-374.
PMID: 33555934
Anxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers.
Anxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers. JCO Oncol Pract. 2021 02; 17(2):e101-e110.
PMID: 33567241
A Qualitative Analysis of Oncology Patient Awareness of Medication Shortages and Their Preferences for How Shortages Should Be Managed.
A Qualitative Analysis of Oncology Patient Awareness of Medication Shortages and Their Preferences for How Shortages Should Be Managed. JCO Oncol Pract. 2020 10; 16(10):e1098-e1111.
PMID: 32469685
Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303.
Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303. J Palliat Med. 2020 07; 23(7):922-929.
PMID: 32031887
A Cross-Sectional Survey of Medical Trainee Experiences During Medication Shortages.
A Cross-Sectional Survey of Medical Trainee Experiences During Medication Shortages. J Grad Med Educ. 2020 Feb; 12(1):38-43.
PMID: 32089792
Mistaking the Trees for the Forest?
Mistaking the Trees for the Forest? Oncologist. 2020 04; 25(4):e743.
PMID: 31873980
Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials.
Garrett SB, Matthews TM, Abramson CM, Koenig CJ, Hlubocky FJ, Daugherty CK, Munster PN, Dohan D. Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials. J Oncol Pract. 2019 Oct 11; JOP1900256.
PMID: 31603726
Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials.
Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials. JCO Oncol Pract. 2020 01; 16(1):e56-e63.
PMID: 31603726